Mice thrive without Cdk4 and Cdk2

Cédric Barrière1, David Santamaría, Antonio Cerqueira

  • 1Molecular Oncology, Centro Nacional de Investigaciones Oncológicas, E-28029 Madrid, Spain.

Molecular Oncology
|April 23, 2009
PubMed

Insights

Cyclin-dependent kinases (Cdk) 4 and 2 are not essential for mammalian cell cycle progression or adult homeostasis. Mice lacking both Cdk4 and Cdk2 survive embryonic development but exhibit distinct phenotypes postnatally.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Mammalian cell division relies on sequential activation of Cyclin-dependent kinases (Cdks), primarily Cdk4, Cdk6, Cdk2, and Cdk1.
  • Viable mice lacking individual Cdk4, Cdk6, or Cdk2 suggest compensatory roles among these kinases.

Purpose of the Study:

  • To investigate the necessity of Cdk4 and Cdk2 in mammalian cell cycle regulation and organismal homeostasis.
  • To elucidate the functional redundancy or essentiality of Cdk4 and Cdk2 during embryonic development and adult life.

Main Methods:

  • Generation and analysis of mice with combined genetic deficiencies in Cdk4 and Cdk2.
  • Conditional ablation of Cdk2 in adult Cdk4-deficient mice.
  • Assessment of survival, physiological function, and cell cycle kinetics in mutant mice and embryonic fibroblasts.

Main Results:

  • Mice lacking both Cdk4 and Cdk2 (Cdk4(-/-);Cdk2(-/-)) survived embryonic development but died shortly after birth, suggesting a critical role during this period.
  • Conditional deletion of Cdk2 in adult Cdk4-deficient mice did not cause apparent abnormalities, and these mice recovered normally from partial hepatectomy.
  • Cdk4(-/-);Cdk2(-/-) embryonic fibroblasts exhibited immortalization, robust pRb phosphorylation, and normal S phase kinetics in culture.

Conclusions:

  • Cdk4 and Cdk2 are dispensable for the progression of the mammalian cell cycle in cultured cells and for maintaining adult homeostasis.
  • The combined absence of Cdk4 and Cdk2 leads to embryonic lethality, indicating essential roles during development that are compensated for in adult tissues.
  • These findings challenge the established view of Cdk4 and Cdk2 as universally essential drivers of the cell cycle in mammals.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...